Jump to main content
Jump to site search


Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy

Author affiliations

Abstract

The bottom-up self-assembly of protein subunits into supramolecular nanoarchitectures is ubiquitously exploited to recapitulate and expand the features of natural proteins to advance nanoscience in medicine. Various chemical and biological re-engineering approaches are available to render diverse functions in the given proteins. They are, unfortunately, capable of compromising protein integrity and stability after extensive modifications. In this study, we introduce a new protein re-engineering method, metal ion assisted interface re-engineering (MAIR), to serve as a robust and universal strategy to extend the functions of self-assembly proteins by boosting structural features to advance their diverse biomedical applications. In particular, the MAIR strategy was applied to a widely used natural protein, ferritin, as a model protein to coordinate with copper ions in its mutagenic artificial metal binding domain. Structure directed rational protein mutagenesis was carried out at the C2 interface amino acid residues of the ferritin subunit for metal ion coordination site optimization. Copper binding at the artificial binding pocket was highly specific over the other divalent ions present in physiological fluids, and the structurally embedded copper ion in turn strengthened the overall protein integrity and stability. In the presence of isotopic copper-64, the interface re-engineered ferritin worked as a chelator-free molecular nanoprobe with an extraordinarily high specific activity to allow PET imaging of tumors in live animals. We also found that the re-engineered ferritin coordinating with copper ions demonstrates high drug loading capacity of a widely used anti-cancer agent, doxorubicin (DOX), to achieve significant drug retention at the tumor site and enhance tumor regression for improved anti-cancer effects. The MAIR approach, thus, exploited the copper ion to facilitate efficient one-step labeling of mutant ferritin derivatives for simultaneous molecular imaging and drug delivery. The reported interface re-engineering strategy provides an unparalleled opportunity to expand protein biofunctions to serve as a new theranostic agent in cancer research.

Graphical abstract: Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Nov 2017, accepted on 03 Dec 2017 and first published on 12 Dec 2017


Article type: Paper
DOI: 10.1039/C7NR08188J
Citation: Nanoscale, 2018, Advance Article
  •   Request permissions

    Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy

    Z. Wang, Y. Dai, Z. Wang, O. Jacobson, F. Zhang, B. C. Yung, P. Zhang, H. Gao, G. Niu, G. Liu and X. Chen, Nanoscale, 2018, Advance Article , DOI: 10.1039/C7NR08188J

Search articles by author

Spotlight

Advertisements